HPV Testing Guidelines Updated for Head and Neck Carcinomas
MDSpire News
April 2, 2025
You now have access to the trusted editorial news and specialty content you've known from the Conexiant news site—all within the MDSpire experience.
Learn more

The College of American Pathologists updated HPV testing guidelines for head and neck carcinomas, expanding on 2018 recommendations.
The new guidelines include seven strong recommendations, four conditional recommendations, and five good practice statements.
Routine HPV testing is recommended for sinonasal squamous cell carcinoma due to its association with a more favorable prognosis.
For fine-needle aspiration specimens, HPV-specific testing is emphasized over p16 immunohistochemistry due to reliability concerns.
The guidelines advise against routine repeat HPV testing for recurrent or metastatic disease if primary tumor HR-HPV status is known.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Affiliations:
Specialties:
Areas of Expertise: